2-Ethyl-3-hydroxy-7,8,9,10-tetrahydro-6H-benzo[c]chromen-6-one

Catalog No.: 
ACBDTF257
CAS No.: 
58926-60-6
Molecular Formula: 
C15H16O3
Molecular Weight: 
244.29
2-Ethyl-3-hydroxy-7,8,9,10-tetrahydro-6H-benzo[c]chromen-6-one structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg95%
1g95%
5g95%
25g95%

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-Ethyl-3-hydroxy-7,8,9,10-tetrahydro-6H-benzo[c]chromen-6-one
IUPAC Name2-ethyl-3-hydroxy-7,8,9,10-tetrahydro-6H-benzo[c]chromen-6-one
MDL No.MFCD02081256
Molecular FormulaC15H16O3
Molecular Weight244.29
SMILESO=C1C2=C(CCCC2)C3=C(O1)C=C(O)C(CC)=C3
InChI KeyULRCJDZFIIRZIM-UHFFFAOYSA-N
Synonym2-Ethyl-3-hydroxy-7,8,9,10-tetrahydro-6H-benzo[c]chromen-6-one;2-ethyl-3-hydroxy-7,8,9,10-tetrahydrobenzo[c]chromen-6-one;BIM-0031557.P001;CBMicro_031555;MLS000061532;Oprea1_386066;SMR000070711;ST5451204
CAS No.58926-60-6

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312+P330-P302+P352-P304+P340+P312-P305+P351+P338-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACBDTF257 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACBDTF257 route product structure diagram
    ACBDTF25758926-60-6In Stock
Inquiry

2. ACBDTF257 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACBDTF257 route product structure diagram
    ACBDTF25758926-60-6In Stock
Inquiry

3. ACBDTF257 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACBDTF257 route product structure diagram
    ACBDTF25758926-60-6In Stock
Inquiry

Comments (0)